LCA-AIPL1 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,354 results for “LCA-AIPL1”

Trials

View all 965 →

A Study of LX107 Gene Therapy in AIPL1-IRD Patients

13 participants · First posted Jul 14, 2025

Not yet recruiting

Safety and Tolerability of Subretinal OPGx-RDH12-1001 for LCA-Associated Inherited Retinal Degeneration (LCA-IRD)

10 participants · First posted Jul 2, 2026

Single Ascending and Multiple Ascending Dose Study of LCA-0061

72 participants · First posted Jul 14, 2026

Drugs

View all 225 →

LCA-60

LCA-AAV7

LCA-10

Organizations

View all 106 →

Rca

Belgium

SANGIORGI LUCA

Italy

CHRYSEA LABS, LDA

Portugal

News

View all 58 →

Breakthrough Gene Therapy Restores Vision in Children with Rare Genetic Blindness

MeiraGTx Advances Gene Therapy Pipeline with FDA RMAT Designation and Pivotal Trial Progress

MeiraGTX's Gene Therapy Shows Promising Visual Benefits in Children with Rare Genetic Blindness

Page 1 of 136